Market Tracker

10/20 5:16pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

43.18
Delayed Data
As of Oct 20
 +0.02 / +0.05%
Today’s Change
36.58
Today|||52-Week Range
44.50
+10.46%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.

Performance

1 month+2.26% 3 years-1.89%
3 months-2.31% 5 years+11.33%
1 year+2.09% Since inception+11.69%
Data through 10/21/2017

Quote Details

Previous close$43.16
Open day’s range43.09 – 43.41
Net asset value (NAV)43.16 (10/20/2017)
Daily volume84,785
Average volume (3 months)93,150
Data as of 7:59pm ET, 10/20/2017

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+11.33%+16.79%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.591.10
Net assets$429.8M$3.1B
Average market cap$9.3B$30.9B
Average P/E27.126.2
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MNK Mallinckrodt Plc4.83%
PFE Pfizer4.78%
LLY Eli Lilly and Co4.71%
PRGO Perrigo Company PLC4.67%
BMY Bristol-Myers Squibb4.64%
AKRX Akorn Inc4.57%
MRK Merck4.55%
JNJ Johnson & Johnson4.53%
ZTS Zoetis Inc4.50%
ENDP Endo International PLC4.48%